HilleVax Inc (HLVX): Earnings per share for the last twelve months

Corporate company logo of HilleVax Inc (HLVX)

HilleVax, Inc. (HLVX) management is currently adjusting its R&D plan following previous difficulties. The trailing twelve-month earnings per share on the GURU.Markets chart shows a sharp impulse, with a value of -1.44. This reinforces the potential of the HIL-214 norovirus vaccine. The absence of competitors in this niche allows the company to pursue a monopoly and establish pricing power for the drug.

HilleVax, Inc. (HLVX) - Net earnings per share (EPS TTM) from 06/21/2023 to 09/27/2025

Analytical breakdowns for HilleVax Corp (HLVX)

- stock price and consensus target price:
Fundamental company analysis:HLVX - HilleVax
Manufactured products of HilleVax Inc

For HilleVax, Inc., which develops norovirus vaccines, this indicator serves as a measure of R&D monetization efficiency. The metric calculates total annual net income divided by the total number of shares. By analyzing the net income per share TTM snapshot on the GURU.Markets platform, an investor can determine the actual per-share income, which allows them to eliminate the impact of share issuance. The indicator's trend reflects the company's sensitivity to the cost of borrowed capital.

Competitor analysis for HilleVax, Inc.

Gilead - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Cidara Corp CDTX|Novavax Corp (NVAX) - Earnings per share for the last twelve months|CureVac N.V. - Earnings per share for the trailing year|Net earnings per share for the last 12 months VALN|Vir Biotechnology (VIR) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months SIGA Technologies Inc (SIGA)|EBS - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) AVIR (Atea Pharma)|Net earnings per share for the last four quarters Invivyd, Inc. (IVVD)|ENTA - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Inovio|Kalaris Therapeutics (KLRS) - Earnings per share for the last twelve months|Dyadic International Inc (DYAI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months NanoViricides Inc.|Talphera Corp - Earnings per one share for the last 12 months|Net earnings per share for the last 12 months COCP (Cocrystal Pharma Inc)|Net earnings per share for the last four quarters Traws Therapeutics|Earnings per share for the last twelve months Dogwood Therapeutics DWTX|Net earnings per share for the trailing year Qualigen Therapeutics, Inc.|ALVR - Earnings per share for the last twelve months|vbivaccines.com (VBIV) - Net earnings per share for the last 12 months|VIRI (virios.com) - Net earnings per share for the last 12 months|VXRT - Net earnings per share for the last four quarters